GLP-1s Tied to Lower Risk of Substance Use Disorders
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Tag: GLP-1 agonists
GLP-1s Tied to Lower Risk of Substance Use Disorders
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Read More
Certain Patients Benefit Most from GLP-1 for Sleep Apnea, Obesity
A subgroup of patients using the GLP-1 tirzepatide experience nearly twice the improvement in sleep apnea severity compared to other participants.
Read More
GLP-1s Tied to Reduced Asthma Exacerbation in Obese Patients
GLP-1 initiation is associated with a 14.6% reduced risk of asthma exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients.
Read More
GLP-1 Agonists May Reduce Asthma Symptoms
Researchers say they found compelling evidence that GLP-1 agonists improved asthma symptoms.
Read More